Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.
Karabela SP, Psallidas I, Sherrill TP, Kairi CA, Zaynagetdinov R, Cheng DS, Vassiliou S, McMahon F, Gleaves LA, Han W, Stathopoulos I, Zakynthinos SG, Yull FE, Roussos C, Kalomenidis I, Blackwell TS, Stathopoulos GT.
Karabela SP, et al.
Carcinogenesis. 2012 Apr;33(4):859-67. doi: 10.1093/carcin/bgs024. Epub 2012 Jan 27.
Carcinogenesis. 2012.
PMID: 22287559
Free PMC article.